These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3591412)

  • 1. Affective impairment in young acute schizophrenics: its structure, course and prognostic significance.
    Lindenmayer JP; Kay SR
    Acta Psychiatr Scand; 1987 Mar; 75(3):287-96. PubMed ID: 3591412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiated short- and long-term effects of a "Training of Emotional Intelligence" and of the "Integrated Psychologic Therapy Program" for schizophrenic patients?].
    Vauth R; Joe A; Seitz M; Dreher-Rudolph M; Olbrich H; Stieglitz RD
    Fortschr Neurol Psychiatr; 2001 Nov; 69(11):518-25. PubMed ID: 11704899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenic thought disorder at followup: its persistence and prognostic significance.
    Harrow M; Marengo JT
    Schizophr Bull; 1986; 12(3):373-93. PubMed ID: 3764358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and prognosis of schizophrenic disorders in light of the Bonn follow-up studies.
    Gross G; Huber G
    Psychopathology; 1986; 19(1-2):50-9. PubMed ID: 3714940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of mood and affect in schizophrenic inpatients.
    Craig TJ; Richardson MA; Pass R; Bregman Z
    Am J Psychiatry; 1985 Nov; 142(11):1272-7. PubMed ID: 4061685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms and emotional blunting in schizophrenic patients.
    de Leon J; Peralta V; Cuesta MJ
    J Clin Psychiatry; 1993 Mar; 54(3):103-8. PubMed ID: 8468308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychopathology and outcome in first-admission schizophrenia: a 13-year follow-up study at a medical school hospital].
    Kobayashi T
    Seishin Shinkeigaku Zasshi; 2001; 103(5):383-410. PubMed ID: 11510079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The core of negative symptoms in schizophrenia: affect or cognitive deficiency?
    Mundt C; Barnett W; Witt G
    Psychopathology; 1995; 28(1):46-54. PubMed ID: 7871120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social cognition of patients with schizophrenia across the phases of illness - A longitudinal study.
    Valaparla VL; Nehra R; Mehta UM; Thirthalli J; Grover S
    Schizophr Res; 2017 Dec; 190():150-159. PubMed ID: 28285028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome predictors in acute schizophrenia. Prospective significance of background and clinical dimensions.
    Kay SR; Lindenmayer JP
    J Nerv Ment Dis; 1987 Mar; 175(3):152-60. PubMed ID: 3819711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential vulnerability markers within the affective domain in subjects at genetic and clinical high risk for schizophrenia.
    Lee SJ; Yoo SY; Kang DH; Lee KJ; Ha TH; Wee W; Lee AR; Kim NS; Kwon JS
    Psychopathology; 2008; 41(4):236-44. PubMed ID: 18408419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight dimensions and cognitive function in psychosis: a longitudinal study.
    Cuesta MJ; Peralta V; Zarzuela A; Zandio M
    BMC Psychiatry; 2006 May; 6():26. PubMed ID: 16737523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PANSS syndromes and quality of life in schizophrenia.
    Karow A; Moritz S; Lambert M; Schoder S; Krausz M
    Psychopathology; 2005; 38(6):320-6. PubMed ID: 16224206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study.
    Bergh S; Hjorthøj C; Sørensen HJ; Fagerlund B; Austin S; Secher RG; Jepsen JR; Nordentoft M
    Schizophr Res; 2016 Aug; 175(1-3):57-63. PubMed ID: 27050475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of chronic schizophrenic patients presenting with severe anhedonia].
    Loas G; Noisette C; Legrand A; Boyer P; Delahousse J
    Encephale; 1996; 22(5):351-8. PubMed ID: 9035991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance.
    Pogue-Geile MF; Harrow M
    Schizophr Bull; 1985; 11(3):427-39. PubMed ID: 4035306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPRS syndrome scales during the course of an episode of psychiatric illness.
    Silverstein ML; Mavrolefteros G; Close D
    J Clin Psychol; 1997 Aug; 53(5):455-8. PubMed ID: 9257223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.